This inventor holds 1 USPTO granted patent. Top assignee: Akzo Nobel N.v.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Wilhelmus H Kuijpers: Innovator in Therapeutic Delivery Systems
Introduction
Wilhelmus H Kuijpers is a notable inventor based in Eindhoven, Netherlands. He has made significant contributions to the field of therapeutic delivery systems, particularly through his innovative patent work. His research focuses on the development of novel therapeutic entities that can effectively target specific diseases.
Latest Patents
One of his key patents is titled "Targeted delivery of a therapeutic entity using complementary." This invention relates to novel labelled modified oligonucleotides that are useful for anti-sense therapy. The patent describes a conjugate of a targeting moiety, such as an antibody, and a modified oligonucleotide that is complementary to the labelled oligonucleotide. The combination of these components is particularly useful in the therapy of viral infections, tumors, and (auto)immunodiseases. Additionally, the patent discloses pharmaceutical formulations that comprise the various compounds involved.
Career Highlights
Wilhelmus H Kuijpers is associated with Akzo Nobel N.V., a leading company in the field of chemicals and coatings. His work at Akzo Nobel has allowed him to explore and develop innovative solutions in therapeutic delivery systems. His contributions have been instrumental in advancing the understanding and application of targeted therapies.
Collaborations
Throughout his career, Kuijpers has collaborated with notable colleagues, including Franciscus M Kaspersen and Constant A Van Boeckel. These collaborations have fostered a productive environment for innovation and research in therapeutic applications.
Conclusion
Wilhelmus H Kuijpers stands out as an influential inventor in the realm of therapeutic delivery systems. His innovative patent work and collaborations have significantly contributed to advancements in medical therapies. His dedication to research continues to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
